Mycoplasma Testing Market Size, Share & Growth Analysis, by Product & Services (Instruments, Assays, Kits, & Reagents, ELISA Assays, Kits, & Reagents, NAT Assays, Kits, & Reagents, Elimination Kits, Stains) by Technology (NAT, ELISA, Staining) by Application (Cell Line Testing, Virus Testing,End-of-Production Cell Testing) by End-use and Regional Forecast to 2031

Request Quote Download FREE Sample
Single User

Table of Contents

  1. Research Methodology
    1.1. Secondary Research
    1.2. Primary Research
    1.3. Market Estimation
    1.3.1. Bottom-up and Top-down Approach
    1.4. Market Forecasting
  2. Executive Summary
  3. Market Overview
    3.1. Market Dynamics
    3.1.1. Drivers
    3.1.2. Restraints
    3.1.3. Opportunities
    3.1.4. Market Trends
    3.2. Industry Speaks
    3.3. Opportunity Analysis
  4. Global Mycoplasma Testing Market- Size & Forecast (2026-2031), By Product & Services
    4.1. Instruments
    4.2. Assays, Kits, & Reagents
    4.2.1. ELISA Assays, Kits, & Reagents
    4.2.2. NAT Assays, Kits, & Reagents
    4.2.3. Elimination Kits
    4.2.4. Stains
    4.2.5. Other Assays, Kits, & Reagents
    4.3. Services
  5. Global Mycoplasma Testing Market- Size & Forecast (2026-2031), By Technology
    5.1. NAT
    5.2. ELISA
    5.3. Staining
    5.4. Other Techniques
  6. Global Mycoplasma Testing Market- Size & Forecast (2026-2031), By Application
    6.1. Cell Line Testing
    6.2. Virus Testing
    6.3. End-of-Production Cell Testing
  7. Global Mycoplasma Testing Market- Size & Forecast (2026-2031), By End User
    7.1. Pharmaceutical & Biotechnology Companies
    7.2. Cell Banks & Laboratories
    7.3. Contract Research Organizations (CROs)
    7.4. Academic Research Institutes
  8. Global Mycoplasma Testing Market- Size & Forecast (2026-2031), By Region
    8.1. North America (U.S. & Canada)
    8.2. Europe (UK, Germany, France, Italy, Spain, Rest of Europe)
    8.3. Asia Pacific (China, India, Japan, Rest of Asia Pacific)
    8.4. Rest of the World (Latin America, Middle East & Africa)
  9. Competitive Landscape
    9.1. Key Players and their Competitive Positioning
    9.1.1. Market Share Analysis (2026)
    9.1.2. Segment-wise Player Mapping
    9.2. Key Strategies Assessment, By Player (2026-2031)
    9.2.1. New Product Launches
    9.2.2. Partnerships, Agreements, & Collaborations
    9.2.3. Mergers & Acquisitions
    9.2.4. Geographic Expansion
  10. Key Companies Scanned (Indicative List)
    10.1. Thermo Fisher Scientific, Inc.
    10.2. Charles River Laboratories International, Inc.
    10.3. Merck KGaA
    10.4. Lonza Group
    10.5. PromoCell GmbH
    10.6. American Type Culture Collection
    10.7. Asahi Kasei Medical Co., Ltd.
    10.8. InvivoGen
    10.9. Sartorius AG
    10.10. Eurofins Scientific